Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

ConditionBloodpressure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity Hospital, Gentofte, Copenhagen

About this trial

The present study investigates the postprandial role of endogenous glucose-dependent insulinotropic polypeptide (GIP) on cardiovascular haemodynamics, hormone responses, and hypotensive symptoms during a tilt test.

Eligibility criteria

Qualifiers

Age 18-40 years

BMI between 18.5 and 29.9 kg/m2 (both included)

Informed consent

Disqualifiers

Allergy or intolerance to ingredients included in the mixed meal

History of Orthostatic Hypotension (OH) or Postural Orthostatic Tachycardia Syndrome (POTS) or other autonomic dysfunction at the discretion of the investigators

Anaemia (haemoglobin below normal range <7.3 mmol/L for women and <8.3 mmol/L for men)

Kidney disease (estimated glomerular filtration rate (eGFR) <90 ml/min/1.73 m2) at screening

Trial design

Treatments tested in this trial

  • GIP(3-30)NH2 / study tool
  • Saline (NaCl 0,9 %) (placebo)
  • GIP(1-42)

Treatment groups

16 Participants
are divided into 4 treatment groups